Clinical trial Recruiting at 2 sites Interventional Ages 35 to 70

Reducing alcohol use among people living with HIV using mobile health tools

Official title: Novel Extensions of Alcohol Contingency Management in People Living With HIV

Run by University of Florida · NCT05153811 · Data updated 2026-11-12

This study is testing if using mobile health tools can help people living with HIV cut down on their alcohol use.

More Alcohol Use trials

Quick facts

Study typeInterventional
Ages35 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Florida
Academic / other
Locations2 sites (Coral Gables, Florida and 1 other locations)
StatusRecruiting
StartedJune 10, 2022
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2026
Registry record updatedJuly 31, 2025
Trial IDNCT05153811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who are HIV positive, have a history of frequent alcohol use, and are willing to engage with mobile health technology for alcohol reduction.

Probably not a fit

Patients with psychiatric conditions that interfere with participation or those currently experiencing alcohol withdrawal may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to implement innovative strategies to reduce alcohol consumption in individuals living with HIV through Contingency Management (CM) techniques. The approach incorporates mobile health (mHealth) tools, including a smartphone breathalyzer and a wrist-worn alcohol biosensor, to monitor and encourage reduced alcohol use. Participants will engage in mobile-facilitated CM for a duration of 30 to 60 days, with follow-up assessments extending up to six months to evaluate the effectiveness of the intervention.

Why it matters

Potential benefit: If successful, this study could significantly improve alcohol use outcomes for individuals living with HIV, enhancing their overall health and quality of life.

How similar studies have gone: Other studies utilizing mobile health interventions for alcohol use reduction have shown promise, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Frequent alcohol use in the past 30 days based on responses on the Timeline Followback (TLFB; Sobell and Sobell, 2003)
* HIV positive
* Fluency in English
* Willingness to attempt alcohol abstinence for at least 30 days and then to attempt alcohol use on fewer days than at baseline after that
* Willingness to use smartphone applications and biosensor devices (i.e., breathalyzer device and wrist sensor) for alcohol use reduction purposes in the study. If participants do not have a compatible smartphone to use, they will be loaned one by the study

Exclusion Criteria:

* Psychiatric conditions that would interfere with participation in the study
* Current alcohol withdrawal as indicated by a score of 8 or higher on the Clinical Institute Withdrawal Scale (CIWA; Sullivan et al., 1989) or lifetime history of medically assisted detoxification
* Two positive breath alcohol concentration (BrAC) readings (i.e., \> 0.00%) at an in-person screening appointment. After participants blow their first positive BrAC, they will be allowed to reschedule and participate at another time, however if they blow a second positive BrAC, they will be excluded from this study and offered referrals for alcohol treatment.
* Currently seeking or past-12-month history of inpatient or intensive treatment for addictive behaviors
* Psychosis or other severe psychiatric disability
* Pregnancy, nursing or lack of reliable birth control use for women who have not yet reached menopause

Where it's running

  • University of Miami
    Coral Gables, Florida, United States
    Recruiting
  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Robert Leeman, Ph.D — University of Florida
  • Study coordinator: Emmely Pavila
  • Email: empavila17@ufl.edu
  • Phone: 352-273-9562

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.